Using Technology to Expand Access to Evidence-Based Therapy

Slides:

Advertisements

Similar presentations

1 The Challenge of Integrating Psychiatry (Behavioral Medicine) into Primary Care Thomas N. Wise, M.D. Professor of Psychiatry Johns Hopkins School of.

Advertisements

TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.

Progress in Understanding the Neurobiology of Schizophrenia Daphne Holt, MD, PhD Director of Research, Schizophrenia Clinical and Research Program Department.

Lessons from Neurobiology: Understanding the Overlap between Pain and Mood Disorders Rakesh Jain, MD, MPH R/D Clinical Research, Inc. Lake Jackson, Texas,

Subtypes of ADHD Related to Substance Use Disorders (SUD): Results from the MGH Longitudinal Study of Boys with ADHD Timothy E. Wilens, MD Massachusetts.

Creating a Culture of Recovery in the VA By Daniel Fisher,MD, PhD Executive Director, National Empowerment Center August 19, 2004, Washington,

Miriam Komaromy, MD Associate Director, Project ECHO Associate Professor, Internal Medicine, UNM 10/2013.

Child Health Disparities Denice Cora-Bramble, MD, MBA Professor of Pediatrics, George Washington University Executive Director Goldberg Center for Community.

From Fellowship to Faculty Salah Qureshi, MD MIRECC Fellow Houston.

Arthur E. Kelley, MD Medical Director, Partnership for Community Care (CCNC) Psychiatric Consultant, Cornerstone Healthcare, High Point, NC.

IPV and meth conference April 27th. Level I (Lab) Chemicals Process Product (meth) Caretaker Behavior Level II (Heavy use; distributing) Neglect Hyper.

Posttraumatic Stress Disorder: Overview, Treatment, Resources Sonya Norman, Ph.D. Researcher, VA San Diego Healthcare System Consultation Program Director,

Washington Association of Alcoholism and Addiction Programs The Sixth Annual Providers Conference April 19-20, 2012.

Behavioral Health Screening & Referral in Pediatric Clinics

Florence THIBAUT Professor of Psychiatry University Hospital Cochin, Paris Paris Descartes University INSERM U 894, Psychiatry and Neurosciences Centre.

Senior Director Substance Use Disorder Initiatives, Community Care Behavioral Health Marge Hanna, MEd.

HIV and Behavioral Health: An Update from SAMHSA Elinore F. McCance-Katz, MD, PhD Chief Medical Officer Substance Abuse and Mental Health Services Administration.

Translating the evidence about mind- body medicine into practice: Barriers and issues in training Victor S. Sierpina, M.D. W.D. and Laura Nell Nicholson.

Safety Net Medical Home Initiative The Commonwealth Fund Webinar December 10, 2014 Integrating Behavioral Health into Primary Care.

The Role of Culture in the Integration of Physical Health Services in Mental Health Settings Leopoldo J. Cabassa, PhD NYS Center of Excellence for Cultural.

Non-communicable Diseases: Integrated Care & Health Policy Eliot Sorel, M.D. Senior Scholar, Clinical Practice Innovations Professor, Global Health, Health.

Sheila Specker, MD American Board of Addiction Medicine Foundation

Sample Text 1 Tobacco in Mental Illness and Addictions : Prevalent and overrepresented Consuming 44% of cigarettes smoked Lethal Treatable, yet remaining.

THE IMPACT OF MARIJUANA ON HEALTH AND HEALTHCARE Ewald Horwath, MD, MS, FAPA Professor and Chair, Department of Psychiatry Associate Clinical Director,

Androgen Therapy for Low Sexual Desire: A Concerned Physician’s View James A. Simon, M.D. Clinical Professor George Washington University Washington, DC.

Nursing 305 The Role of the Psychiatric Nurse. Pre-requisites for the Role:  Self awareness is a key part of the psychiatric nursing experience.  You.

Multidimensional Family Therapy for Adolescent Drug Abuse: Research Update and Illustration of Core Clinical Methods Presented at the 2005 Joint Meeting.

Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.

Exploration of the Substance Abuse Treatment Workforce: Education, Preparation and Certification Traci Rieckmann, Ph.D., Bret Fuller, Ph.D, Dennis McCarty,

Integrated Behavioral Health Planning Meeting October 25, 2013 Debra Hurwitz, MBA, BSN, RN CSI Co-Director 1.

Evidence for Specificity of Transmission of Alcohol and Nicotine Dependence in an Offspring of Twins Sample Heather E Volk MPH, Jeffrey F Scherrer PhD,

Schizophrenia: why is it important in South-East London? Robin M Murray Professor of Psychiatric Research Institute of Psychiatry at the Maudsley, Kings.

Long-term Efficacy Data for Psychiatric Drugs Rationale for Long-Term Treatment Earl Giller, MD, PhD Pfizer Global Research & Development Long-Term Efficacy.

Greater Burden of Psychopathology

Collaborative Addiction Research in Asian Populations Home and Abroad Gavin Bart, MD PhD FACP FASAM Director, Division of Addiction Medicine Department.

Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.

Management of Substance Use Disorder Module P: Addiction-Focused Pharmacotherapy.

ACAMPROSATE Lipha Pharmaceuticals, Inc. May 10, 2002 Psychopharmacologic Drugs Advisory Committee Meeting May 10, 2002 Psychopharmacologic Drugs Advisory.

Long-term Efficacy for Psychiatric Drugs Frederick K. Goodwin, MD George Washington University Medical Center Frederick K. Goodwin, MD George Washington.

An Innovative Mental Health Center. Reasons for HOPE: Advances in Mental Health Care Presented by Paul E. Keck, Jr., M.D. President and Chief Executive.

Integrated Health Care Integrated primary and mental health care for individuals with severe mental illness (SMI) Judith Lloyd Storfjell, PhD, RN, FAAN.

DISEASES OF MENTAL STATUS AND ELDER ABUSE. Delirium  Disturbance of consciousness with deficits of attention and changes in cognition or perception that.

6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.

Moving the Needle: Toward Value-Based Integrated Mental Health Services for Patients with Chronic Medical Conditions James G Baker MD MBA Associate Chair,

Premorbid temperament as a predictor for remission in depression

Cognitive Behavioral Therapy for Eating Disorders

Hepatitis C Incidence and Prevalence in the U.S.

Expansion of Early Psychosis Care in U.S. Community Settings

Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.

Professor of Clinical Psychiatry

Jaber Filho, JA: Veríssimo Jr, J; ,Hollanda, A; Trapaga, R.

whole food diet & depression risk

VACS Opioids Workgroup

البرامج المتكاملة لعلاج استخدام المخدرات جامعة كاليفورنيا، لوس أنجلوس

BORDERLINE PERSONALITY DISORDER AND TRUST

Screening for Substance Abuse Disorders Using ‘Single’ Questions

Obsessive Compulsive Disorder: A Clinical Update

Fellow Emily Prince: 2nd year Developmental/Clinical Psychology doctoral candidate Mentors Daniel Messinger: Professor of Psychology, Pediatrics, Music.

Object exploration times before (Pre) and after (Post) the 4-wk protocol. Object exploration times before (Pre) and after (Post) the 4-wk protocol. During.

Assessing Opioid Use Disorder, part 1

Gerry Maitland Clinical Sciences

Pica Derek S. Mongold MD.

Diagnosis and Recognition of OUD

Psychiatry in Ontario: Current Evidence and Future State AGHPS Leadership Summit 2018 Paul Kurdyak MD PhD Scientist, Institute for Mental Health Policy.

Eric Arzubi, MD Chair, Department of Psychiatry Billings Clinic

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

The Opioid Crisis: What Can Be Done for the Children

Sex Differences in Mental Illness

Volume 2, Issue 5, Pages (May 2015)

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

Presentation transcript:

Using Technology to Expand Access to Evidence-Based Therapy Daniel Z. Lieberman, M.D. Associate Professor of Psychiatry and Behavioral Sciences Director, Clinical Psychiatric Research Center George Washington University (202) 741-2899 dlieberman@mfa.gwu.edu

Substance Use Disorders 21.8 million Grant BF et al. Arch Gen Psych. 2004 61:807-816

Substance Use Disorders 21.8 million Substance Use Disorders 16% 21.8 million Grant BF et al. Arch Gen Psych. 2004 61:807-816

Substance Use Disorders 21.8 million Substance Use Disorders 16% 21.8 million ? Grant BF et al. Arch Gen Psych. 2004 61:807-816

Lieberman DZ. Am J Addict. 2005;14(2):155-65

Lieberman DZ. Am J Addict. 2005;14(2):155-65

Low Levels of Recognition and Action. Higher Levels of Ambivalence Lieberman DZ. Am J Addict. 2005;14(2):155-65